Spectrum Brands Holdings, Inc. Q3 2025 results
Snapshot
Spectrum Brands Holdings, Inc. reported $700M of revenue in Q3 2025, up -10.2% year over year, with diluted EPS of $0.80 and an operating margin of 4.5%.
- Revenue
- $700M
- YoY growth
- +-10.2%
- Diluted EPS
- $0.80
- Operating margin
- 4.5%
What management said
- •tariff rate on Chinese imports dropped to 30%, only then did our businesses begin to strategically place orders again, and we only bought product where we knew we could price them for tariffs.
- •When we faced material inflationary headwinds, our playbook is to cover our margin structure through a combination of supplier concessions, internal cost reductions, and yes, unfortunately, pricing.
- •Again, doing the right thing to avoid massive long-term P&L hits meant we had to lose a significant amount of revenue in the third quarter.
- •We've had to prioritize investments that would be the most impactful to both this year and into the future, given softer consumer demand in some of our categories.
- •Operating income of $31.3 million decreased by $16.4 million, driven by the gross margin decline, partially offset by the lower operating expenses I mentioned.
- •GAAP net income and diluted earnings per share both increased, primarily driven by lower interest expense, reduced income tax expense, and lower share count, partially offset by lower operating income and lower investment income.
- •Adjusted diluted EPS increased to $1.24, driven by reduced income tax expense, lower interest expense, and the reduction in shares outstanding, partially offset by lower adjusted EBITDA.
- •Capital expenditures were $10 million in Q3, essentially flat to last year.
- •Cash payments towards strategic transactions, restructuring-related projects, and other unusual non-recurring adjustments were $8.6 million versus $10.5 million last year.
- •Moving now to the balance sheet, we had a quarter-end cash balance of $122 million and $388.5 million available on our $500 million cash flow revolver.
- •Total debt outstanding was approximately $681 million, consisting of borrowings on our cash flow revolver of $103 million, $496 million of senior unsecured notes, and $82 million of finance leases.
- •Reported net sales decreased 9.6%, and excluding favorable foreign currency impacts, organic net sales decreased 11.4%.
What went well
- •Executed a rapid mitigation of the 'tariff torpedo' within 90 days, pausing China finished-good purchases when U.S. rates hit 145% (and up to 170%) and only resuming strategic orders when rates dropped to 30% in mid-May, protecting long-term margin structure.
- •Took out over $50 million of costs in fiscal 2025 through reduction-in-force across all business lines and corporate, eliminating or delaying backfill of open positions, cutting discretionary spend and shrinking real estate footprint.
- •Put tariff-related pricing in place with practically all customers by quarter-end, with sales levels already improving and Q4 off to a good start with more normalized sales than Q3.
- •Maintained a healthy, unlevered balance sheet with $122 million in cash and $388.5 million available on the $500 million revolver, continuing aggressive share repurchases (bought back almost half the float).
- •Diversified the supplier base by developing and activating non-Chinese sourcing alternatives, targeting the lowest all-in cost of supply for each market.
What went wrong
- •Q3 net sales declined 10.2% (organic down 11.1%), driven by targeted stop shipments to certain retailers, supply constraints, category softness in Global Pet Care and Home & Personal Care, and unfavorable weather in Home & Garden.
- •Adjusted EBITDA fell $29.7 million to $76.6 million (down $17 million excluding prior-year investment income), driven by lower volume and reduced gross margins, with gross margin down 110 bps to 37.8%.
- •An estimated $30 million of sales were left on the table in Q3 from stop shipments and internal actions, concentrated in Global Pet Care and Home & Personal Care.
- •Up to eight weeks without product importation left the company out of stock on some main SKUs, with orders in Global Pet Care and Home & Personal Care that could not be filled, lingering partly into Q4.
Guidance changes
| Metric | Period | Previous | Current | Change |
|---|---|---|---|---|
| Formal guidance | Fiscal 2025 | Not provided | Still not provided, citing ongoing tariff/trade volatility making accurate prediction irresponsible | |
| Q3 sales lost to stop shipments / internal actions | Q3 fiscal 2025 | Not applicable | Approximately $30 million, expected to be quite a bit less in Q4 | |
| Cost reductions | Fiscal 2025 | Not applicable | Over $50 million expected |
Performance breakdown
| Metric | YoY change | Reason |
|---|---|---|
| Net sales | -10.2% (organic -11.1%) | Targeted stop shipments to certain retailers, supply constraints, category softness in Global Pet Care and Home & Personal Care, and unfavorable cold/wet weather delaying Home & Garden replenishment; $6.8 million favorable FX. |
| Gross margin | -110 bps (to 37.8%) | Lower volume, unfavorable mix, inflation and higher tariffs, partially offset by pricing, cost improvement actions, operational efficiencies and favorable FX. |
| Adjusted EBITDA | -$29.7 million (to $76.6 million); -$17 million excl. prior-year investment income | Prior-year investment income of $12.7 million, lower volume and reduced gross margins, partially offset by expense management and lower investments. |
| Operating income | -$16.4 million (to $31.3 million) | Gross margin decline, partially offset by lower operating expenses (down 8.7% on reduced advertising/marketing and restructuring spend). |
| Adjusted diluted EPS | Increased to $1.24 | Reduced income tax expense, lower interest expense and reduced shares outstanding, partially offset by lower adjusted EBITDA. |
| Global Pet Care reported net sales | -9.6% (organic -11.4%) | Decision to stop shipping to a handful of customers during tariff-related pricing negotiations, tariff-related supply issues from the China import pause, and a large retailer's capacity constraints; companion animal organic down low double digits and aquatics down low teens. |
| Global Pet Care adjusted EBITDA | -$12.7 million (to $44 million); margin 17.2% vs 20.1% | Lower sales volumes, unfavorable mix and inflation, partially offset by operational productivity, lower brand-focused investments and FX. |
Earnings call themes & trends
| Topic | Previous mention | Current period | Trend |
|---|---|---|---|
| Tariff response | Hit by the 'tariff torpedo'; controlling what is controllable | Took swift, draconian actions (China purchase pause, stop shipments, pricing, cost cuts); confident the right decisions were made and benefits are starting to show | |
| Pet category and competition | Struggled to hold share amid trade-downs and private label over prior four quarters | Improving versus private label in the U.S.; feels the category has bottomed and is starting to get a little better, with pricing in place and new leadership reinvigorating messaging | |
| M&A strategy | Vision to triple Pet and double Home & Garden | Chased a deal in the quarter but got outbid by private equity; maintaining discipline on price/returns while preserving balance sheet flexibility, with a slowly improving but still uncertain M&A environment | |
| Consumer environment | Weakness emerged in U.S. last fall, Europe following | Consumer more resilient than expected; sentiment expected to heal globally as tariff volatility calms, though consumers remain judicious and value-seeking | |
| Pricing for fiscal 2026 | Not specified | Targeting only ~$20-$25 million of incremental pricing and supplier concessions annualized to mitigate 2026 tariffs, equating to less than 1% of the ~$3 billion revenue base |
Q&A summary
Can you quantify how much sales you left on the table by stopping shipments and other internal actions in Q3, and what lingers into Q4?
David Maura said 'a lot and less'; Jeremy Smeltser estimated roughly $30 million in Q3, expected to be quite a bit less in Q4.
Why is guidance still so difficult even with improved tariff clarity, when other companies have reinstated or updated outlooks?
David Maura declined to give guidance, saying the company manages its own business, Q3 contains a ton of noise from shutting inputs for two months and selling stops for weeks plus $50 million of cost cuts, that the stock should not be priced off Q3, and that July is off to a great start setting up for a great 2026.
Can you give more color on the pet category and channel mix, share gains, and the supply constraint?
Jeremy Smeltser said the category is still declining for chews and treats driven by consumer sentiment and trade-downs, but the company got its pricing through on chews, has started to improve versus private label in the U.S., and believes pet has bottomed; stop shipments and product availability (mostly U.S., some Europe around a global customer's warehouse constraints) suppressed net sales while POS share was at least maintained.
Are you seeing major volatility in shipping or container rates?
David Maura said 'No'; Jeremy Smeltser added the company is pretty steady on contract rates with strong ocean freight carrier relationships and does not see anything disrupting the normal Q4 pace barring a trade negotiation blow-up.
What is your capital allocation strategy in a soft consumer environment, and are investment priorities changing?
David Maura said the whole space is undervalued and the company keeps buying back shares daily (having bought back almost half the float) while wanting to do disciplined M&A; he reiterated the vision to triple Pet and double Home & Garden and noted Spectrum chased a deal but got outbid, with plenty of capital available.
Has the M&A environment improved meaningfully with the new tariff map, or is there still too much uncertainty?
David Maura said it is both: uncertainty makes troubled assets hard to underwrite and risks catching a falling knife, but there is a lot of capital around; the company was outbid by private equity on a good fit, seller expectations remain too high, and the environment is improving but slower than they'd like.
How much of the ~$30 million left on the table can you make up, and how does it split between HPC and H&G?
Jeremy Smeltser clarified it does not really impact Home & Garden but rather HPC and GPC; about half has already been recovered, contributing to the solid July, while some POS will be permanently missed, with no overall meaningful full-year impact expected.
What is your view on consumer demand in Home & Garden across price points, and how much pricing are you planning?
David Maura said the consumer has been more resilient than expected and is value-seeking, supporting bullishness on shelf resets and branded product; Jeremy Smeltser contrasted value-brand Home & Garden gaining share in every category with pet's trade-down pressure that is now improving, and said fiscal 2026 incremental pricing/concessions of only ~$20-$25 million annualized equate to less than 1% of revenue, applied strategically.